n acute ischemic stroke, the diffusion-weighted imaging (DWI) lesion is commonly considered a surrogate marker of irreversible core, and this underpins all MR methods currently in use to screen candidates for reperfusion therapy, notably according to the perfusion (PWI)-DWI mismatch model. 1 Accurate assessment of DWI lesion volume is also crucial to establish cutoffs above which thrombolysis may not be beneficial and may even be harmful. However, the reliability of the DWI hyperintense lesion as a depiction of the infarct core is challenged by reports of occasionally sustained, albeit often partial, DWI lesion reversal after reperfusion. [2] [3] [4] [5] [6] [7] [8] Permanent DWI lesion reversal is well established in the animal literature using temporary artery occlusion models. 9 In human stroke, DWI lesion reversal was initially reported immediately after intra-arterial therapy. 6 A systematic review suggested that the rate of permanent DWI reversal was substantial and highlighted the potential unreliability of DWI hyperintensities for infarct core imaging. 10 Although DWI lesion reversal after reperfusion is a well-accepted phenomenon, studies have been discrepant regarding its exact extent. 3, 8, 11, 12 Moreover, the clinical implication, if any, of DWI lesion reversal is unclear. In the prospective multicenter Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study of patients treated by intravenous tissue-type plasminogen activator (tPA) 3 to 6 hours after stroke onset, DWI lesion reversal was associated with early reperfusion and a favorable clinical outcome. 8 However, in a further analysis of DEFUSE, pooled with the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) data, the amount of DWI reversal was reported as small and hence Background and Purpose-In acute stroke, diffusion-weighted imaging (DWI) lesions are commonly considered markers of irreversible ischemia yet can occasionally reverse. However, the extent and clinical correlates of DWI reversal in thrombolyzed patients remain unclear. We assessed the extent of reversible acute DWI lesions (RADs) and their relationships with clinical outcome in patients thrombolyzed ≤4.5 hours from onset. Methods-Data were retrospectively analyzed. RAD was defined as an acute DWI lesion not part of a 24-hour DWI lesion as determined voxelwise. Associations with an early neurological improvement (early neurological improvement=ΔNational Institutes of Health Stroke Scale ≥8 or National Institutes of Health Stroke Scale ≤2 at 24 hours) or an excellent outcome (modified Rankin Scale ≤1) were assessed in multivariate analyses. Results-One hundred seventy-six patients were included. The median (interquartile range) time to treatment from onset was 150 minutes . Eighty-nine patients (50%) exhibited visually-detectable RAD irrespective of its extent. Over the whole population, the median percentage and volume of RAD were 11% (4-36) and 2.4 mL (0.5-8). Subtracting RAD from initial DWI altered perfusion-weighted imaging-DWI classification in 5 of 100 patients (shift from "no mismatch" to "mismatch" profile in all). Percent RAD was significantly greater in patients treated ≤3 hours (P=0.049), without proximal occlusion (P=0.003), and in 24-hour recanalizers (P<0.001). Early neurological improvement was independently associated with percent RAD. This association increased with percent RAD split in quartiles in a "dose-dependent" manner (P for trend=0.01). Excellent outcome was independently associated with percent RAD (P for trend <0.001). In addition, this pooled analysis concluded that DWI lesion reversal did not substantially affect the occurrence of the PWI-DWI mismatch profile and therefore had no appreciable impact in the clinical setting. Beyond these apparent discrepancies, the extent of DWI lesion reversal in the current time window for intravenous thrombolysis, namely 0 to 4.5 hours, is not known nor are its clinical correlates.
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n acute ischemic stroke, the diffusion-weighted imaging (DWI) lesion is commonly considered a surrogate marker of irreversible core, and this underpins all MR methods currently in use to screen candidates for reperfusion therapy, notably according to the perfusion (PWI)-DWI mismatch model. 1 Accurate assessment of DWI lesion volume is also crucial to establish cutoffs above which thrombolysis may not be beneficial and may even be harmful. However, the reliability of the DWI hyperintense lesion as a depiction of the infarct core is challenged by reports of occasionally sustained, albeit often partial, DWI lesion reversal after reperfusion. [2] [3] [4] [5] [6] [7] [8] Permanent DWI lesion reversal is well established in the animal literature using temporary artery occlusion models. 9 In human stroke, DWI lesion reversal was initially reported immediately after intra-arterial therapy. 6 A systematic review suggested that the rate of permanent DWI reversal was substantial and highlighted the potential unreliability of DWI hyperintensities for infarct core imaging. 10 Although DWI lesion reversal after reperfusion is a well-accepted phenomenon, studies have been discrepant regarding its exact extent. 3, 8, 11, 12 Moreover, the clinical implication, if any, of DWI lesion reversal is unclear. In the prospective multicenter Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study of patients treated by intravenous tissue-type plasminogen activator (tPA) 3 to 6 hours after stroke onset, DWI lesion reversal was associated with early reperfusion and a favorable clinical outcome. 8 However, in a further analysis of DEFUSE, pooled with the Echoplanar
Labeyrie et al DWI Reversal After Thrombolysis 2987
unlikely to be clinically relevant. 11 In addition, this pooled analysis concluded that DWI lesion reversal did not substantially affect the occurrence of the PWI-DWI mismatch profile and therefore had no appreciable impact in the clinical setting. Beyond these apparent discrepancies, the extent of DWI lesion reversal in the current time window for intravenous thrombolysis, namely 0 to 4.5 hours, is not known nor are its clinical correlates.
In the present study, we therefore aimed to characterize the extent of DWI reversal in a large sample of patients treated within the currently licensed time window. To this end, we used state-of-the-art voxel-based image processing rather than simple volume analysis. We hypothesized that DWI reversal would be sizeable within this early time period and that it would be associated with neurological improvement.
Methods

Patients
This was a retrospective analysis based on a prospectively collected register of consecutive patients treated by recanalization therapy for ischemic stroke between January 2006 and December 2010. Since 2006, MRI is systematically implemented in our center as first-line diagnostic work-up (ie, in place of CT) in candidates for thrombolysis. The standard MR protocol 13, 14 includes fluid-attenuated inversion recovery, DWI, T2*, intracranial MR angiography as well as PWI whenever feasible with no delay. MR-specific criteria to treat included diagnosis of ischemic stroke, and exclusion criteria included DWI, PWI, and MR angiography, all normal. DWI-PWI patterns, hypoperfusion, or DWI lesion volumes were not a basis for clinical decision-making except in borderline cases. A follow-up MR was scheduled around 24 hours after treatment and included the same set of sequences as the admission MR except PWI. Patients included in the present study were those treated by intravenous tPA (0.9 mg/ kg) and/or endovascular treatment within 4.5 hours after stroke onset and who had both pretreatment and follow-up MRI (<72 hours). Exclusion criteria were lack of baseline or follow-up MRI, marked artifact on DWI/MR angiography, or recanalization therapy initiated >4.5 hours. Intravenous tPA was administered within 3 hours until November 2008 and within 4.5 hours thereafter. Endovascular treatment was used in selected cases using intra-arterial tPA and/or thrombectomy. For each patient, we prospectively recorded demographic details: stroke onset-to-MRI and onset-to-treatment times; National Institutes of Health Stroke Scale (NIHSS) score, blood pressure and serum glucose; and modified Rankin Scale at discharge. The study was approved by the local ethics committee.
MR Protocol
Pretreatment MR (MR 1 ) and follow-up MR (MR 2 ) were performed on a 1.5-T scanner (SignaEchoSpeed; GE Healthcare). Briefly, DWI consisted of a single-shot echoplanar spin-echo sequence (3 directions, b=1000 s/mm 2 ). Maps of the apparent diffusion coefficient were generated. Pretreatment PWI was obtained using a T2*-weighted echoplanar sequence, TR/TE 2000/60, field of view 24×24 cm 2 , one number of excitations, 64×96 matrix, and repetition 50 times after a bolus (5-7 mL/s) of 20 mL of gadoteric acid. The total acquisition time ranged from 7 to 10 minutes.
Image Analysis
Stroke arterial distribution (anterior/posterior circulation), motion artifacts on DWI or PWI, and hemorrhagic transformation on MR 2 according to European Cooperative Acute Stroke Study (ECASS) classification criteria from the T2* sequence were recorded. MR images were processed on a workstation (Advantage Workstation; GE Healthcare) using an application for functional mapping calculation (READY View). MR 1 images were coregistered to MR 2 using an automated 3-dimensional rigid registration (Integrated Registration), visually checked, and manually corrected whenever necessary. The pretreatment and follow-up DWI lesions (DWI 1 and DWI 2 , respectively) were first segmented using interactive tools based on DWI signal intensity thresholding within a 3-dimensional rectangular mask encompassing the apparent area of bright DWI signal intensity and morphometric filtering. The segmented DWI voxels were projected onto apparent diffusion coefficient maps to exclude any areas of T2 shine-through effects and include any areas of decreased apparent diffusion coefficient with subtle DWI signal changes missed by automated thresholding. Hemorrhagic transformations were manually included in the segmentation of DWI 2 to avoid overestimating any reversal of the DWI lesion. Image processing was performed by a board-certified neuroradiologist (M.-A.L.) and visual check and manual corrections by consensus of 2 radiologists (M.-A.L., C.O.), all blinded to clinical data.
Changes in DWI lesions were automatically determined using a voxel-based comparison of coregistered DWI 1 and DWI 2 data sets. "Reversible acute DWI lesion" (RAD) voxels were defined as those DWI 1 voxels that did not overlap with the coregistered DWI 2 ( Figure  1 ). RADs were expressed in percentage of RAD (%RAD) defined as (volume RAD /volume DWI1 )×100. RADs with both Vol RAD >10 mL and %RAD >10% ( Figure 2 ) were documented according to, and for comparison with, earlier studies. 11 Finally, presence or absence of RAD was qualitatively assessed on coregistered DWI 1 /DWI 2 by consensus of the 2 readers.
To determine the extent of PWI-DWI mismatch, PWI data were postprocessed using BrainStat arterial input function (READY View) software for an automated generation of time-to-maximum maps. These were obtained by circular deconvolution of the tissue concentration time course using an arterial input function from contralateral arteries. In this study, time to maximum, that is, the time of maximum sample of residue function, was corrected for slice acquisition timing differences using temporal interpolation and was thus a continuous parameter. The following steps were then performed: extracting a brain mask of apparent diffusion coefficient <1300.10 -6 mm 2 /s to remove cerebrospinal fluid voxels; projecting this mask onto time-to-maximum maps for brain voxels extraction; and segmenting the severely hypoperfused voxels according to time to maximum >6 seconds threshold, as recommended by others. 11, 15 Posterior circulation strokes or lesions with hypoperfused volume <10 mL were excluded from the perfusion analysis. 16 We then determined the impact of DWI lesion reversal, if any, on patient classification as mismatch present or absent. The PWI-DWI mismatch profile was first considered present according to the usual voxel-based definition, that is, hypoperfused voxels that did not overlap with hyperintense voxels on coregistered DWI 1 and Volume hypoperfusion >1.2×Volume DWI1 . 16 We then subtracted the RAD voxels from the DWI 1 lesion to obtain a "post hoc-corrected" mismatch classification, that is, taking "hidden penumbra" into account.
Pretreatment occlusion was categorized into proximal (carotid, basilar artery, or proximal post-Willisian segment), distal or absent. Recanalization was defined according to Thrombolysis In Myocardial Infarction criteria, dichotomized into presence (Thrombolysis In Myocardial Infarction 2-3) or absence (Thrombolysis In Myocardial Infarction 0-1) of recanalization. Occlusion and recanalization were assessed on 3-dimensional time-of-flight MR angiography and/or PWI data or based on the presence of fluid-attenuated inversion recovery hyperintense and/or T2*-susceptibility vessel signs for questionable distal occlusions.
Clinical Outcome
Early neurological improvement (ENI) was defined as a gain of NIHSS ≥8 within the first 24 hours or NIHSS ≤2 at 24 hours. 17 Excellent functional outcome was defined as modified Rankin Scale ≤1 at hospital discharge.
Statistical Analysis
Statistical analysis was performed using SPSS 15.0 (SPSS Inc). Continuous variables were described as median and interquartile range and compared using the nonparametric Wilcoxon test.
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Categorical variables were compared using χ 2 or Fisher exact test, as appropriate.
The relationship between RAD and clinical data was assessed in a univariate analysis of pre-and posttreatment variables associated with ENI. We further assessed the relationship between %RAD and ENI in a multivariate binary logistic regression model adjusted for previously published major clinical outcome predictors (ie, potential confounders), namely age, pretreatment NIHSS, systolic blood pressure, In this analysis, %RAD was split into quartiles to assess whether the association with ENI increased in a "dose-dependent" manner with %RAD. An additional (sensitivity) multivariate analysis was performed using a stepwise backward variable selection method (entry for P<0. 20) to ensure that the associations were not due to statistical overfitting. We finally assessed the association of %RAD quartiles with excellent functional outcome in a new logistic regression model adjusted for the same potential confounders.
Results
Clinical Material
During the study period, 218 patients underwent recanalization therapy. Forty-two were excluded because of a time to treatment >4.5 hours (n=11), contraindication to MRI (n=9), no MR 1 and/or MR 2 (n=15), or severe DWI/MR angiography artifacts (n=7). Eligible patients did not differ from noneligible patients in age, sex, or NIHSS score. The main characteristics of the 176 eligible patients are summarized in online-only Data Supplement Table I . Fifteen (9%) were treated within the first 90 minutes, 99 (56%) in the 90-to 180-minute time window and 62 (35%) in the 3-to 4.5-hour time window with no significant differences in baseline parameters between patients treated before and after 3 hours. The median (interquartile range) time to MRI 2 was 24 hours (20-29) after treatment and 26 hours (22-31) after stroke onset. Of these, 100 also had PWI acquired as part of MR 1 . This subgroup did not differ from that without PWI for any of the pre-or posttreatment variables.
DWI Lesion Reversal
The median (interquartile range) %RAD across the whole sample was 11% (4-36) with a volume of 2.4 mL (0.5-8). Thirty patients (17%) had both RAD >10 mL and %RAD >10%, of which 7 had total or subtotal (≥95%) RAD ( Figure  2 ). Eighty-nine patients (50%) had visually detectable RAD, of which 84 had %RAD above the 11% median value ( online-only Data Supplement Table II ). In the population with visually present RAD, the %RAD rose to 35% (18-65) with a median volume of 8 mL (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Across the whole sample, %RAD was greater for patients treated within the first 3 hours than for those treated in the 3-to 4.5-hour window (14% versus 9% [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ; P=0.049). Percent RAD was greater in patients with distal or no occlusion than in those with proximal occlusion (19% versus 9% [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] ; P=0.003) and in patients with subsequent recanalization as compared with the rest of the sample (17% 
versus 6% [2-13]; P<0.001).
The PWI-DWI mismatch profile was present in 91 of 100 patients (volume of DWI 1 =18 mL ; PWI=94 [38-128] mL). There was a nonsignificant trend for patients with PWI-DWI mismatch to have a greater %RAD than other patients (10% versus 7% [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] ; P=0.08). The post hoc RAD correction altered the PWI-DWI mismatch classification in 5 patients (5%), who shifted from the "no mismatch" to the "mismatch" profile. In these patients, the median (minimum-maximum) of %RAD and Vol RAD were 11.2% (4.5-15) and 7 (5-18) mL, respectively.
Relationship With Clinical Outcome
At 24 hours posttreatment, 55 (31%) patients had experienced ENI. As expected, they were significantly younger, were treated earlier, and had a higher rate of recanalization and smaller DWI 1 and DWI 2 volumes than those without ENI. Patients with ENI had greater %RAD (median, 40% versus 8%; P<0.001; Table) . In multivariate analysis, %RAD, split into quartiles, was independently associated ENI with a significant stepwise increase (P for trend=0.01; online-only Data Supplement Table III) . On hospital discharge, 46 (26%) patients had an excellent outcome, which was independently associated with %RAD quartiles (P for trend (P<0.001), serum glucose (P=0.04), and pretreatment NIHSS (P=0.001).
In sensitivity analyses, the associations between %RAD (split in quartiles) and ENI or between %RAD and excellent outcome remained significant in alternative multivariate logistic regression models or using a stepwise backward variable selection method (data not shown). Also, all of these results remained significant when patients with nonanterior circulation stroke and those not treated exclusively with intravenous tPA were excluded post hoc (data not shown).
Discussion
Capitalizing on a large sample to address the issue of acute DWI lesion reversal in patients treated within the currently licensed time window for intravenous tPA, we found that %RAD involved >11% of the initial DWI lesion in half of patients. Although rarely total, %RAD involved a sizeable part of the initial DWI lesion in patients with ENI (median, 40%). Moreover, %RAD was independently associated with ENI in a "dose-dependent" manner. Unless specified, numbers are median (interquartile range). BP indicates blood pressure; NIHSS, National Institutes of Health Stroke Scale; DWI, diffusion-weighted imaging; PWI, perfusion-weighted imaging; RAD, reversible acute diffusion-weighted imaging lesion. *n=100; percent corresponds to Volume Mismatch/Volume hypoperfusion× 100.
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The reported prevalence of RAD varies between studies, [2] [3] [4] [5] [6] 8, 11, 12, 18 with extremes from 7% 11 to 85%. 6 Discrepancies in rates of occurrence are likely explained by differences in the operational definition of RAD, particularly in the timing of both acute and follow-up imaging. Imaging follow-up scheduled too early after treatment may not capture all of the reversible process, which can be delayed a few hours after reperfusion 2 but may also consider as permanent some transient DWI lesion reversals. 7 Indeed, although permanent DWI lesion reversal is a well-established notion in the animal literature, acute DWI reversal can be followed by delayed secondary injury. 9, 19 In animal models, secondary injury after acute DWI reversal peaks around 12 hours after recanalization. 9 In human stroke, although studies have demonstrated DWI reversal on follow-up MRI carried out a few hours posttreatment, and secondary injury on 7-to 30-day follow-up MRI, 2, 7, 11 interleaved MRIs have been lacking and the full temporal profile of this phenomenon remains partly unknown. On the other hand, very late follow-up (≥90 days) exposes to the confounding effect of infarct shrinkage and potential overestimation of RAD. 12 Our RAD definition was based on follow-up DWI performed around 24 hours after treatment, 20 which minimizes the confounding effect of vasogenic edema 20, 21 and at the same time should be late enough to capture both most instances of early DWI reversal and delayed secondary injury at the same time as avoiding infarct shrinkage. Twenty-four-hour DWI instead of late fluid-attenuated inversion recovery follow-up also overcomes the risk of overestimating infarct size due to peri-infarct gliosis and/or premorbid leukoaraiosis. It also minimizes patient attrition 16 and DWI-to-fluid-attenuated inversion recovery coregistration errors 12 and allows for more reproducible measurements. 20 Accordingly, 24-hour DWI lesion volumes predict functional outcome equally well as late fluid-attenuated inversion recovery infarct volumes. 20 Our findings shed new light on the issue of RAD extent within the reperfusion therapy time window. The increase in %RAD with shorter onset-to-treatment time found here suggests that the less prolonged the ischemia, the more likely the chance of DWI lesion reversibility. This is consistent with previous work suggesting more frequent RAD occurrence with short onset-to-treatment time. 5 In turn, the fact that in our study the onset-to-treatment time was particularly short (median, 2.5 hours) likely explains why RAD was more prominent here than in studies performed in the 3-to 6-hour interval. 11, 12 Within this extended time window, only 3.4% of patients had RAD >10 mL and %RAD >10% in the pooled DEFUSE and EPITHET data set. 11 This relatively low rate compared with ours (17%) is at least in part accounted for by the longer onset-to-tPA delay (mean, 5 hours) and by a significant proportion (30%) of EPITHET patients who received placebo and therefore were less prone to prompt reperfusion. 11 Within the 0-to 4.5-hour interval, half of our thrombolyzed patients had ≥11% of the initial DWI lesion that escaped infarction, and %RAD was >36% in (1 of 4) patients. This is in keeping with the few published data on DWI reversibility within a similar time window and assessed as here using voxel-based image processing on coregistered images. For instance, in another series of 42 patients, of which 27 were treated with intravenous tPA within 4.5 hours of stroke onset, almost half the initial DWI lesion escaped infarction. 3 In another study, sustained RAD was present, according to visual assessment, in 35% of 31 patients treated with intravenous tPA within 3 hours. 5 On the other hand, although RAD volume and %RAD were substantial in a sizeable fraction of the sample, the actual RAD volume was small in most instances with a switch from no mismatch to mismatch profile in 5% of patients only, consistent with previous reports. 11, 12 This fact reflects the thresholds used here to define the mismatch profile (time to maximum >6 seconds and ratio >1.2). Using this definition here in the ≤4.5-hour time window, only 9 patients belonged to the no-mismatch profile, 5 of whom shifted to the mismatch profile after taking RAD into consideration. The impact of RAD in patients with the no-mismatch profile may therefore not be negligible in the early time window. Given that correcting for RAD can only cause a shift in profile from the "no mismatch" to the "mismatch," its impact on mismatch classification inevitably increases the more stringent the threshold. 12 Percent RAD showed the expected relationship with other key determinants of ischemic severity and response to treatment, namely onset-to-treatment time, presence/type of arterial occlusion, PWI-DWI mismatch, and recanalization. One salient finding from this study is the independent relationship between DWI lesion reversal and favorable clinical response to treatment, which increased in a "dose-dependent" manner with %RAD. This finding indirectly strengthens not only the validity of our methodology to identify RAD, but also the view that the ischemic penumbra extends into the acute DWI lesion. 5, 6, 8, 22, 23 As expected, age, initial DWI volume, and recanalization were also associated with ENI. However, the association with RAD was independent of these and other clinical and radiological variables, although, importantly, functional outcome was also independently associated with RAD. Taken together, our findings therefore support the notion that within the current intravenous thrombolysis time window, reversal of acute DWI lesion, albeit partial in most cases, is a real phenomenon with clinical correlates.
This study has several limitations. First, it did not distinguish transient from sustained RAD, a phenomenon with a still unclear clinical significance. 5, 7 Second, that RAD correlates with ENI does not imply that it alone accounts for ENI. In those patients with small reversal volumes, ENI is likely to have almost entirely derived from concomitant reperfusion of adjacent hypoperfused regions, which was not studied here. However, in those patients with %RAD in the upper quartile, ENI is likely in part explained by reperfusion of the DWI lesion itself. Given that the salvaged penumbra is directly responsible for neurological improvement, even relatively small RADs in peri-infarct areas might play a significant clinical role. 24 Finally, the relationship between RAD and timely reperfusion could not be optimally documented, because recanalization was assessed based on the 24-hour MR follow-up.
Summary
On a pathophysiological standpoint, and consistent with the notion that DWI may contain penumbral tissue, we document the existence and clinical correlates of the RAD phenomenon in patients treated within 4.5 hours from stroke onset.
